From AI to VR, and everything in between—explore the cutting-edge tools revolutionizing medical training. Learn why these advancements are crucial for maintaining standards and excelling in the ...

Sanofi’s Sarclisa (isatuximab) has been approved by the Medicines and Healthcare product Regulatory Agency (MHRA) as part of a combination treatment for newly diagnosed multiple myeloma (MM).

The UK-wide Innovative Licensing and Access Pathway (ILAP) was first launched in 2021 to reduce the time to market for innovative medicines by offering drug developers a single platform to collaborate ...

Levi Garraway, Roche’s chief medical officer and head of global product development, said: “The INAVO120 overall survival ...

If 2024 saw an unparalleled acceleration in the wider public’s awareness of AI, then 2025 will be the year when its practical application becomes mainstream.

Biogen has announced that the European Medicines Agency (EMA) and US Food and Drug Administration (FDA) have started ...

Novo Nordisk’s Ozempic (semaglutide) has been approved by the US Food and Drug Administration (FDA) to reduce the risk of ...

Bayer Consumer Health has launched a digital educational resource to support perimenopausal or menopausal patients in the UK.

Open communication Good, open communication between all is clearly paramount before, during and on return to work. But the preference for how that is done, the frequency and what is communicated ...

AstraZeneca (AZ) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved by the US Food and Drug ...

Roche and Sarepta Therapeutics have shared positive top-line results from a late-stage study of Elevidys (delandistrogene ...

In trials at University College London Hospitals (UCLH), an ASO is being used to target the mutated gene that results in the ...